Accent Microcell MD, chairman and AGM

Accent Microcell board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Statutory auditor

Named in the results for the quarter to Mar 2026.

T R Chadha & Co LLPPeer-review certificate valid to Sep 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Accent Microcell AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Accent Microcell dividend history

Annual general meeting, 31 Jul 2026

3,407 shareholders on the register on 24 Jul 2026; present: 10 promoters and 16 others; votes counted by Sunil A. Mulchandani / M/s Sunil Mulchandani & Associates.The company's voting result (opens in a new tab)

Adoption of Audited Financial Statements together with all annexures for the financial year ended on 31st March, 2026
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
Declaration of dividend on equity shares for financial year ended march 31, 2026
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
Ordinary Resolution for Re-appointment of Mr. Vinod Manibhai Patel (DIN: 07698117) as Director of the Company retiring by rotation
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
To confirm the re-appointment of mr. Vasant vadilal patel (din: 05225561) as executive chairman and whole-time director of the company and approval of his remuneration
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
To confirm the re-appointment of mr. Ghanshyam arjanbhai patel (din: 05225398) as managing director of the company and approval of remuneration
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
To confirm the re-appointment of mr. Nitin jasvantbhai patel (din: 05225550) as whole-time director of the company and approval of remuneration
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
To confirm the re-appointment of mr. Vinodbhai manibhai patel (din: 07698117) as whole-time director of the company and approval of remuneration
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
Appointment of Ms. Pooja Dharmesh Shah (DIN: 10851564) as an Independent Director of the Company
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%
Ratification of remuneration to cost auditor
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 65.04% · promoters 98.62% · institutions 57.43% · other public 26.85%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Dealings with its subsidiaries, promoters, directors and their firms, reported every half-year.Promoters and their stake

Half-year to Sep 2026: ₹9.3 Cr16 dealings
Half-year to Mar 2026: ₹35.8 Cr17 dealings

Between	Dealing
Accent Microcell Limited and Jainishk IndustriesOne of the directors son and brother is a partner in the firm	Purchase of goods or services	17.00	2.67	1.40	0.00
Accent Microcell Limited and Accent Biosciences Private LimitedTwo common director's in the company.	Purchase of goods or services	17.00	2.43	−0.92	−0.83
Accent Microcell Limited and Maccent Biocare IndustriesOne of the director's brother is a partner in the firm	Purchase of goods or services	17.00	1.89	0.02	0.38
Accent Microcell Limited and Jainishk IndustriesOne of the directors son and brother is a partner in the firm	Sale of goods or services	17.00	1.16	2.44	0.00
Accent Microcell Limited and Globe Star Valves Private LimitedOne of the director is common in the company.	Purchase of fixed assets	17.00	0.52	0.23	0.00
Accent Microcell Limited and Claroid Pharmaceuticals LimitedOne of the director is common in the company.	Sale of goods or services	17.00	0.31	1.40	0.37
Accent Microcell Limited and Aneta Pharmaceuticals Private LimitedOne of the director is common in the company.	Sale of goods or services	17.00	0.12	0.06	0.16
Accent Microcell Limited and Brohks Healthcare Private LimitedOne of the directors son is a Director in the company	Purchase of goods or services	17.00	0.07	−6.59	0.00
Accent Microcell Limited and Brohks Healthcare Private LimitedOne of the directors son is a Director in the company	Sale of goods or services	17.00	0.07	5.40	₹24,000
Accent Microcell Limited and Globe Star Valves Private LimitedOne of the director is common in the company.	Purchase of goods or services	17.00	0.03	0.00	0.00
Accent Microcell Limited and Globe Star Engineers (India) Pvt LtdOne of the director's brother is a director in the company.	Purchase of goods or services	17.00	0.03	0.00	−₹25,000
Accent Microcell Limited and Ashutosh Corporate LLPOne of the directors son and brother is a designated partner in the firm	Purchase of fixed assets	17.00	0.01	−0.01	0.00
Accent Microcell Limited and Indo SMC LimitedOne of the director is common director in the company.	Purchase of fixed assets	17.00	₹46,000	−₹28,000	−₹17,000
Accent Microcell Limited and Ashutosh Corporate LLPOne of the directors son and brother is a designated partner in the firm	Purchase of goods or services	17.00	₹44,000	0.00	0.00
Accent Microcell Limited and Globe Star Engineers (India) Pvt LtdOne of the director's brother is a director in the company.	Purchase of fixed assets	17.00	0.00	−₹59,000	0.00
Accent Microcell Limited and Maccent Biocare IndustriesOne of the director's brother is a partner in the firm	Sale of goods or services	17.00	0.00	4.69	0.00

The 16 largest of 16 dealings in the half-year to Sep 2026, ₹ crore.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

Received
Resolved

Open at the quarter's end

None open at any quarter's end.

The filing has a part on fines and penalties: No
The filing has a part on tax disputes: No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Sep 2026. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

Raised	Amount raised	For	Set aside	Spent	Spent elsewhere	Spent elsewhere, amount
Public IssuesDec 2023	78.40	To set up plant for manufacturing Croscarmellose Sodium (CCS), and Sodium Starch Glycolate (SSG) and Caboxymethylcellulose (CMC)	54.39	72.48	No	18.09
Public IssuesDec 2023	78.40	General Corporate Purposes	17.90	11.22	No
Public IssuesDec 2023	78.40	Issue Related Expenses	6.10	6.58	No	0.48
Rights IssuesJul 2025	39.77	To Set up plant for manufacturing of Microcrystalline Cellulose	32.33	62.80	No	30.47
Rights IssuesJul 2025	39.77	General Corporate Purposes	6.94	1.06	No
Rights IssuesJul 2025	39.77	Issue Related Expenses	0.50	0.59	No	0.09

₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.